1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
41 Cellular function activating agents
|
42 Antineoplastics
|
421 Alkylating agents
|
422 Antimetabolites
|
423 Antibiotics
|
424 Plant extract preparations
|
429 Miscellaneous
|
4291 Other Antitumors
|
D00068 Alcohol (USP); Anhydrous ethanol (JP18)
D00094 Tretinoin (JAN/USP/INN)
D09960 Ruxolitinib phosphate (JAN/USAN)
D01370 Cladribine (JAN/USP/INN)
D03021 Azacitidine (JAN/USAN/INN)
D06199 Trabectedin (JAN/USAN/INN)
D02166 Mitoxantrone hydrochloride (JAN/USP)
D01441 Imatinib mesylate (USAN); Imatinib mesilate (JAN)
D03658 Dasatinib (JAN/INN)
D06414 Dasatinib (USAN); Dasatinib hydrate (JAN)
D06413 Nilotinib hydrochloride hydrate (JAN)
D09728 Bosutinib hydrate (JAN)
D09951 Ponatinib hydrochloride (JAN/USAN)
D11404 Asciminib hydrochloride (JAN/USAN)
D01977 Gefitinib (JP18/USAN/INN)
D04023 Erlotinib hydrochloride (JAN/USAN)
D09733 Afatinib dimaleate (USAN); Afatinib maleate (JAN)
D10766 Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)
D10514 Dacomitinib (USAN); Dacomitinib hydrate (JAN)
D09996 Vemurafenib (JAN/USAN/INN)
D10104 Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN)
D11053 Encorafenib (JAN/USAN/INN)
D09731 Crizotinib (JAN/USAN/INN)
D10551 Ceritinib (JAN/USAN/INN)
D10450 Alectinib hydrochloride (JAN)
D10866 Brigatinib (JAN/USAN)
D11012 Lorlatinib (JAN/USAN/INN)
D10176 Trametinib dimethyl sulfoxide (JAN/USAN)
D10604 Binimetinib (JAN/USAN/INN)
D10372 Palbociclib (JAN/USAN)
D10688 Abemaciclib (JAN/USAN/INN)
D06068 Temsirolimus (JAN/USAN/INN)
D02714 Everolimus (JAN/USAN/INN)
D00753 Sirolimus (JAN/USAN/INN)
D04024 Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)
D03218 Axitinib (JAN/USAN)
D10223 Ibrutinib (JAN/USAN)
D10893 Acalabrutinib (JAN/USAN/INN)
D11417 Pemigatinib (JAN/USAN/INN)
D11725 Futibatinib (JAN/USAN/INN)
D06402 Sunitinib malate (JAN/USAN)
D06272 Sorafenib tosylate (USAN); Sorafenib tosilate (JAN)
D05380 Pazopanib hydrochloride (JAN/USAN)
D06407 Vandetanib (JAN/USAN/INN)
D10137 Regorafenib hydrate (JAN)
D10095 Cabozantinib s-malate (USAN); Cabozantinib malate (JAN)
D09920 Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)
D09956 Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN)
D11138 Larotrectinib sulfate (JAN/USAN)
D10800 Gilteritinib fumarate (JAN/USAN)
D10926 Entrectinib (JAN/USAN/INN)
D10891 Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN)
D11073 Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN)
D11713 Selpercatinib (JAN/USAN/INN)
D11371 Capivasertib (JAN/USAN)
D02994 Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN)
D09321 Obinutuzumab (USAN/INN); Obinutuzumab (genetical recombination) (JAN)
D10777 Daratumumab (USAN); Daratumumab (genetical recombination) (JAN)
D11967 Daratumumab and hyaluronidase
D11050 Isatuximab (USAN/INN); Isatuximab (genetical recombination) (JAN)
D03257 Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN)
D05446 Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN)
D09980 Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN)
D11529 Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN)
D03455 Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN)
D05350 Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN)
D10018 Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN)
D10316 Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)
D10574 Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN)
D10808 Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN)
D10817 Avelumab (USAN/INN); Avelumab (genetical recombination) (JAN)
D10773 Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN)
D11108 Cemiplimab (USAN); Cemiplimab (genetical recombination) (JAN)
D06409 Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
D09371 Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN)
D04603 Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN)
D09587 Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN)
D10559 Dinutuximab (USAN/INN); Dinutuximab (genetical recombination) (JAN)
D09325 Blinatumomab (USAN/INN); Blinatumomab (genetical recombination) (JAN)
D09337 Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN)
D09761 Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN)
D11525 Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN)
D10761 Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN)
D06657 Tremelimumab (USAN/INN); Tremelimumab (genetical recombination) (JAN)
D12368 Epcoritamab (USAN/INN); Epcoritamab (genetical recombination) (JAN)
D11934 Pertuzumab, trastuzumab and hyaluronidase
D00275 Cisplatin (JP18/USP/INN)
D01363 Carboplatin (JP18/USP/INN)
D01790 Oxaliplatin (JAN/USP/INN)
D00478 Procarbazine hydrochloride (JP18/USP)
D03106 Bexarotene (JAN/USAN/INN)
D03150 Bortezomib (JAN/USAN/INN)
D12311 Bortezomib hydrate (JAN)
D08880 Carfilzomib (JAN/USAN/INN)
D10131 Ixazomib citrate (JAN/USAN)
D06320 Vorinostat (JAN/USAN)
D06637 Romidepsin (JAN/USAN/INN)
D10019 Panobinostat lactate (JAN)
D09730 Olaparib (JAN/USAN/INN)
D11895 Niraparib tosilate hydrate (JAN)
D10733 Talazoparib tosylate (USAN); Talazoparib tosilate (JAN)
D02997 Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN)
D10517 Crisantaspase (JAN/INN)
D05387 Pegaspargase (JAN/USAN/INN)
D02106 Arsenic trioxide (JP18/USAN)
D03682 Denileukin diftitox (USAN/INN); Denileukin difitox (genetical recombination) (JAN)
D08914 Eribulin mesylate (USAN); Eribulin mesilate (JAN)
D10679 Venetoclax (JAN/USAN/INN)
D11485 Tazemetostat hydrobromide (JAN/USAN)
D12055 Sotorasib (JAN/USAN)
D11390 Daunorubicin and cytarabine
D00966 Tamoxifen citrate (JP18/USP)
D00967 Toremifene citrate (JAN/USAN)
D01161 Fulvestrant (JAN/USP/INN)
D00586 Flutamide (JP18/USP/INN)
D00961 Bicalutamide (JP18/USP/INN)
D10218 Enzalutamide (JAN/USAN)
D11040 Apalutamide (JAN/INN)
D11045 Darolutamide (JAN/USAN/INN)
D00960 Anastrozole (JP18/USP/INN)
D00964 Letrozole (JAN/USP/INN)
D00963 Exemestane (JAN/USP/INN)
D09701 Abiraterone acetate (JAN/USP)
D11027 Ropeginterferon alfa-2b (INN); Ropeginterferon alfa-2b (genetical recombination) (JAN)
D02802 Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN)
D00754 Thalidomide (JAN/USP/INN)
D04687 Lenalidomide (JAN/USAN/INN)
D09813 Lenalidomide hydrate (JAN)
D08976 Pomalidomide (JAN/USAN/INN)
D03308 Iobenguane I 131 (USP); 3-Iodobenzylguanidine (131I) (JAN)
D04489 Ibritumomab tiuxetan (USAN/INN); Ibritumomab tiuxetan (genetical recombination) (JAN)
D10398 Radium Ra 223 dichloride (USAN)
D11033 Lutetium (177Lu) oxodotreotide (INN)
D01404 Sobuzoxane (JAN)
D01416 Nedaplatin (JAN/INN)
D01418 Tamibarotene (JAN/USAN/INN)
D04245 Forodesine hydrochloride (JAN/USAN)
D06294 Miriplatin hydrate (JAN)
D08898 Darinaparsin (JAN/USAN)
D10819 Aflibercept beta (genetical recombination) (JAN)
D10993 Tucidinostat (JAN/USAN/INN)
D11070 Tirabrutinib hydrochloride (JAN/USAN)
D11272 Borofalan (10B) (JAN)
D11527 Zolbetuximab (USAN/INN); Zolbetuximab (genetical recombination) (JAN)
D11662 Valemetostat tosilate (JAN)
D11920 Pimitespib (JAN)
D12058 Elranatamab (USAN); Elranatamab (genetical recombination) (JAN)
|
4299 Others
|
43 Radioactive drugs
|
44 Allergic agents
|
49 Other agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|